Position in NSPR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$54,722
-$5,036 QoQ
Shares Held
33,572
0.0% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NSPR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $7,432,227,699 across 107 Medical Devices names. NSPR ranks #98 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
19,394,974 | $1,991,281,976 | |
| 2 | SYK |
Stryker Corp
|
3,303,484 | $1,085,491,802 | |
| 3 | MDT |
Medtronic plc
|
12,036,821 | $1,042,990,536 | |
| 4 | BSX |
Boston Scientific Corp
|
13,373,881 | $839,211,030 | |
| 5 | EW |
Edwards Lifesciences Corp
|
5,824,369 | $466,415,465 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
4,052,065 | $288,425,981 | |
| 7 | DXCM |
Dexcom Inc
|
3,425,025 | $215,091,565 | |
| 8 | STE |
STERIS plc
|
908,765 | $200,955,200 |
All Filings in NSPR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,722 | 33,572 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $59,758 | 33,572 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $80,908 | 33,572 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $102,876 | 45,320 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $120,751 | 44,889 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $126,297 | 48,022 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $63,166 | 23,570 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $60,580 | 24,232 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $59,700 | 25,190 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $79,910 | 28,438 | Shares | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||